Structure of Human Cytomegalovirus Immune Modulator UL141

N-acetyl-beta-D-glucosamine; 2-acetamido-2-deoxy-beta-D-glucose; 2-acetamido-2-deoxy-D-glucose; 2-acetamido-2-deoxy-glucose; N-ACETYL-D-GLUCOSAMINE

The structure of cytomegalovirus immune modulator UL141 highlights structural Ig-fold versatility for receptor binding.

SFPFATADIAEKMWAENYETTSPAPVLVAEGEQVTIPCTVMTHSWPMVSIRARFCRSHDGSDELILDAVKGHRLMNGLQY
RLPYATWNFSQLHLGQIFSLTFNVSTDTAGMYECVLRNYSHGLIMQRFVILTQLETLSRPDEPCCTPALGRYSLGDQIWS
PTPWRLRNHDCGMYRGFQRNYFYIGRADAEDCWKPACPDEEPDRCWTVIQRYRLPGDCYRSQPHPPKFLPVTPAPPADID
TGMSPWATRGHHHHHH

0.2 M calcium acetate, 0.1 M imidazole pH 8, 10% (w/v) polyethylene glycol 8000, VAPOR DIFFUSION, SITTING DROP, temperature 295.15K

Structure of HCMV UL141 bound to TRAIL-R2

HYDROGENS HAVE BEEN USED IF PRESENT IN THE INPUT

viral protein in complex with human receptor, Immunoglobulin-like V-set folg of N-terminal domain; Ig-like beta sandwich domain, viral immunomodulator, host-virus interaction, TRAIL-R2, CD155, glycosylation, membrane, CELL ADHESION

SFPFATADIAEKMWAENYETTSPAPVLVAEGEQVTIPCTVMTHSWPMVSIRARFCRSHDGSDELILDAVKGHRLMNGLQY
RLPYATWNFSQLHLGQIFSLTFNVSTDTAGMYECVLRNYSHGLIMQRFVILTQLETLSRPDEPCCTPALGRYSLGDQIWS
PTPWRLRNHDCGMYRGFQRNYFYIGRADAEDCWKPACPDEEPDRCWTVIQRYRLPGDCYRSQPHPPKFLPVTPAPPADID
TGMSPWATRG